To increase manufacturing capacity Inovio partners with Thermo Fisher Scientific... Sep 09
The vaccine was found to be safe, immunogenic and well tolerated in the pre-clinical toxicity studies, it also able to elicit high level of ... Aug 05
The primary objective of the study was to evaluate the immune response and safety of the vaccine, and to determine the most suitable dose for ... Jul 21
Human dosing of the vaccine marks a key milestone since the launching of the accelerated vaccine development programme for COVID-19 in February 2020.... Jul 15
-Advertisements-